Insider trades
Eric Easom, CEO of AN2 Therapeutics ANTX, has filed 3 purchases and 1 sale on the open market. The latest trade was on 03/19.
Eric Easom
CEO
- Company
- AN2 Therapeutics ANTX
- First filing
- 23/02/24
- Trades
- 18 trades
- Buys / sales
- 3 / 1
- 12-month net buying
- No record
- Last trade
- 03/19
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
AN2 TherapeuticsANTX | Open-market buy | 25/06/02 | 25/06/03 | 10,000 sh | $1.07 | $10,700 | +4.1% |
AN2 TherapeuticsANTX | Open-market buy | 24/11/18 | 24/11/18 | 50,000 sh | $1.00 | $50,000 | +4.9% |
AN2 TherapeuticsANTX | Open-market sale10b5-1 plan | 24/01/02 | 24/01/04 | 2,777 sh | $20.09 | $55,789.93 | −56.6% |
AN2 TherapeuticsANTX | Open-market buy | 23/05/15 | 23/05/15 | 10,000 sh | $5.38 | $53,800 | +1.0% |